Mark Frissora is a Fortune 500 business executive, board chairman and non-executive member with 40-plus years of experience in senior corporate leadership for both public and private companies with a ...

Mark Miller, co-founder of Historic Agency, leads product strategy, marketing transformation and brand. He has rebranded nearly 100 organizations and specializes in all things strategy including brand ...

“New explosions in biotechnology are allowing us to interrogate cancers at a very sophisticated level compared to before,” Dennis Slamon told audience members at ...

IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...